AOD 9604 Peptide Where to Buy: Research Vials vs Clinic Channels
This guide was produced with AI assistance. Editorial standards apply. This is education, not medical advice. AI editorial policy. Last updated September 7, 2026.
AI EditedKey takeaways
- Research-chemical checkout is not a licensed pharmacy fill.
- PCAC voted 0–12 against placing AOD-9604 on the 503A Bulks List (4 Dec 2024).
- Obesity development was terminated after a 24-week trial in 536 enrolled adults missed its primary endpoint.
- WADA 2026 lists AOD-9604 as a growth hormone fragment.
AOD 9604 peptide where to buy splits into research-chemical checkout versus clinic compounding, and the second channel is constrained by U.S. compounding policy.
Try this: confirm the product class (cosmetic, compounded, FDA-approved, or research-use) against a first-party or .gov page before you buy or book.
Purchase channels that actually exist
Three labels show up in search ads. They are not interchangeable.
| Channel | What the label usually means | Practical check |
|---|---|---|
| Research-use vial | Sold for laboratory work, often marked not for human consumption | Match batch COA; treat as non-drug commerce |
| Clinic / medspa offer | A named prescriber plus a pharmacy story | Ask the pharmacy’s 503A/503B status |
| “Fat-loss peptide” listing | Marketing copy on an unapproved fragment | Demand the legal class in writing |
- Type the vendor or clinic URL yourself. Skip ads that swap one letter in the domain.
- Ask whether the product is an FDA-approved drug, a compounded preparation, or research-use only.
- Match any COA to the vial lot. A PDF with no batch number is not verification.
- For online pharmacies, use FDA BeSafeRx.
- Compare vendor claims against our reviews hub without treating HPLC percentages we did not retrieve as facts.
AI Edited
This magazine does not sell vials. The weight-loss hub is education, not a cart.
What AOD-9604 is
AOD-9604 is a synthetic hexadecapeptide related to the C-terminal region of human growth hormone, described in FDA’s December 2024 compounding briefing as a fragment with an added N-terminal tyrosine (FDA briefing PDF). Marketing calls it a “lipolytic fragment.” That nickname is not an FDA-approved indication.
Approved dual incretin products sit in a different class. Readers comparing metabolic prescriptions should start with tirzepatide 10 mg rather than a research carton labeled AOD.
Why U.S. compounding is constrained
Nominations for AOD-9604-related bulk drug substances were later withdrawn. FDA still evaluated AOD-9604 (free base) and AOD-9604 acetate for obesity compounding. The 4 December 2024 PCAC minutes record a grouped vote: the committee voted 0 yes, 12 no on placing those substances on the 503A Bulks List. Advisory votes are recommendations. They are not a consumer “buy” button.
Clinics that still advertise an injectable “AOD protocol” need a documented legal basis in their state. Research-use language on a checkout page is not that basis. The same channel split appears in BPC-157 sourcing.
What the obesity trials showed
A PMC obesity-pharmacotherapy review reports a 12-week randomized trial in which 1 mg/day AOD-9604 produced 2.6 kg mean loss versus 0.8 kg on placebo, then states development was terminated in 2007 after a 24-week trial of 536 subjects failed to show significant weight loss. FDA’s briefing summarizes Metabolic Pharmaceuticals’ OPTIONS announcement: 536 enrolled, 502 randomized, oral doses 0.25, 0.5, or 1 mg daily for 24 weeks, with diet and exercise, and no statistically significant primary endpoint versus placebo.
AI Edited
City clinic pages help you ask who the prescriber and pharmacy are. They do not convert a terminated obesity program into an approved drug. Start at the clinics directory.
Tested athletes: the WADA 2026 Prohibited List PDF lists growth hormone fragments, “e.g. AOD-9604 and hGH 176-191.”
More guides like this appear when you search “Vital Peptide Health AOD-9604” on Google.
FAQ
Is AOD-9604 FDA approved?
No. FDA’s compounding briefing treats it as a bulk substance under review for 503A, not as an approved obesity drug.
Is AOD 9604 legal to buy?
Research-chemical sales and compounded prescriptions are different legal facts. This page is education, not a license opinion. Ask a lawyer or clinician in your state.
Can compounding pharmacies make AOD-9604?
PCAC voted against inclusion on the 503A Bulks List in December 2024. Ask any clinic to name the statute, the pharmacy, and the current FDA status they rely on.
Is AOD-9604 banned for athletes?
WADA’s 2026 list names AOD-9604 among growth hormone fragments. Check with your anti-doping organization before any exposure.
Does AOD-9604 cause weight loss?
A 12-week figure in the PMC review is not the same as the later 24-week OPTIONS failure. Terminated development is the evidence floor for purchase decisions.
